These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors. Author: Lagente V, Hichami A, Boichot E, Martins MA, Silva PM. Journal: Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653. Abstract: Asthma is now recognized as an inflammatory disease associated with eosinophil infiltration into the pulmonary tissue. It has appeared in recent years that phosphodiesterase type IV inhibitors presented all the necessary characteristics to be used as new anti-asthmatic drugs. Indeed, in addition to their bronchodilator properties, they have inhibitory activities on inflammatory cell infiltration into the lung and on inflammatory mediator release. However, the mechanism of action of phosphodiesterase inhibitors, theoretically linked to the increase in intracellular cAMP, is now largely open for discussion.[Abstract] [Full Text] [Related] [New Search]